Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Neurology
»
Multiple Sclerosis
15. October 2026
Search
medline.ch
Multiple Sclerosis
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Alzheimer
Epilepsy
Infections
Headache
Multiple Sclerosis
Neoplasms
Neuromuscular Diseases
Parkinson
Cerebrovascular Diseases
CNS Trauma
Others
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Rect Top
Anzeige
Zoom:
Page 1 of 2253
Articles 1 - 20 / 45041
Cerebrospinal fluid amino acid alterations are associated with oxidative stress and neuronal injury markers in multiple sclerosis.
Metab Brain Dis
Bartová R, Slezáková D, .
PMID: 42873354 [PubMed - indexed for MEDLINE]
Association of Physician-Patient Communication and Treatment Satisfaction with Adherence to Disease-Modifying Therapies Among Patients with Relapsing-Remitting Multiple Sclerosis: A Cross-Sectional Study.
Patient Prefer Adherence
Chojdak-, Ko, Pucciarelli G, Budrewicz S, Pokryszko-Dragan A.
PMID: 42872059 [PubMed]
Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis.
Front Immunol
Ling Z, Liu X, Li W, Wang Q, Tan N, Ding X, Zan Y, Gu Y, Qian Y, Luo X, Trinh T, Li Y, Lv X, Wang M, Tan Q, Zhu K, Zheng C, Yao X, Zhu J, Huang J, Yao Y, Shen N.
PMID: 42871097 [PubMed - indexed for MEDLINE]
Apathy-depression overlap: unmasking hidden disability profiles in multiple sclerosis.
Front Neurol
Oliveri S, Massaro F, Tambussi C, Piscopo K, Guidetti M, Zaccone T, Mingione A, Monzani C, Marceglia S, Vegni E, Priori A, Martinelli Boneschi F.
PMID: 42870876 [PubMed - indexed for MEDLINE]
Correction: A target trial emulation of the CONFIRM study with an extension to subgroups: an example for relapsing-remitting multiple sclerosis.
Eur J Epidemiol
Verweij S, Bijlsma MJ, Oude Rengerink K, Hillert J, Forsberg L, Mouresan EF, Glaser A, Fox RJ, Hak E, Mol P.
PMID: 42870146 [PubMed - as supplied by publisher]
Multiple sclerosis: Advances in diagnosis, biomarkers, and disease management.
J Neuroimmunol
Grund E, Cross AH, Chahin S.
PMID: 42868862 [PubMed - as supplied by publisher]
Anti-CD20 Drugs and Natalizumab Confer Equal Protection Against Progression Independent of Relapse Activity (PIRA) in People With Multiple Sclerosis.
Eur J Neurol
Palazzo L, Clarelli F, Surano M, Giordano A, Moiola L, Clinical SanRaf MS Study Group, Rocca MA, Filippi M, Esposito F.
PMID: 42867409 [PubMed - indexed for MEDLINE]
Multiple Sclerosis During Pregnancy and the Postpartum Period: Diagnostic and Multidisciplinary Challenges in Two Cases.
Int Med Case Rep J
Syahidah PN, Irianti S, Mose JC, Cahyani A, Rhamdani N.
PMID: 42865872 [PubMed - indexed for MEDLINE]
How well do junior neurology residents recognize multiple sclerosis? Analysis of the "Close the Loop" resident clinical acumen project.
Mult Scler
Zbrzeski C, Schorr EM, Polineni SP, Brandstadter R, Fabian MT, Krieger SC.
PMID: 42864844 [PubMed - as supplied by publisher]
Long-term neuropsychiatric outcomes in offspring of mothers with multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study.
Mult Scler Relat Disord
Chung YH, Heo J, Kwon S, Jeon HJ, Cho J, Kang D, Min JH.
PMID: 42863234 [PubMed - as supplied by publisher]
When sex matters early: clues from pediatric onset multiple sclerosis.
Expert Rev Neurother
Lorefice L, Zivadinov R.
PMID: 42861823 [PubMed - as supplied by publisher]
Glucagon-Like Peptide-1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review.
Ann Clin Transl Neurol
Chang AY, Mateen FJ.
PMID: 42860897 [PubMed - as supplied by publisher]
Prevalence and Odds of Bipolar Disorder in Patients with Multiple Sclerosis (MS): a Systematic Review and Meta-Analysis.
Maedica (Bucur)
Pourshams M, Rashidpour P, Malekpour N, Rastkar M, Ghajarzadeh M, Shirkhoda SA.
PMID: 42859432 [PubMed]
Comment on "Lacosamide effects on pain management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial".
Mult Scler Relat Disord
Sokmen O.
PMID: 42858538 [PubMed - as supplied by publisher]
Real-world effectiveness and safety of Ocrelizumab in a gulf multiple sclerosis cohort: extension of the Q-OCRE study to 451 patients.
Mult Scler Relat Disord
Zammar K, Abualrob MA, Yasin R, Althani A, Alemadi A, Hassanein D, Alshehab S, Baniamer Y, Eltazi I, Sayed Abdelmoneim M, Ahmed F, Mallat F, Khodair R, Hamid S, Garcia-Cańibano B.
PMID: 42858537 [PubMed - as supplied by publisher]
Multiple sclerosis occurrence with gut microbial metabolites and sex hormones.
Mult Scler Relat Disord
ParsaSefat M, Bahar A, Mashhadi MJ, Yosefi S, Khazai M, Tahmasebi H.
PMID: 42858536 [PubMed - as supplied by publisher]
Comparator Event Rates, Baseline Activity, and Operational Selection Pressure in Relapsing Multiple Sclerosis Trials: A Meta-Epidemiological Analysis.
Eur J Neurol
Pfeuffer S, Masanneck L, Pawlitzki M, Hartung HP.
PMID: 42858119 [PubMed - indexed for MEDLINE]
Melatonin supplementation in multiple sclerosis: a systematic review of clinical, imaging, biomarker, and safety outcomes.
Front Neurol
Nabil Y, Ghazou A, Abodabesh S, Mansour A, Adel Mohamed A, Allam S, Eid N, Wahba YI, Mamoun RMM, Samy A, Hanna KE, Noufal A, Seyed EKA, Meshref M.
PMID: 42856919 [PubMed - indexed for MEDLINE]
The implementability of healthcare professional-led physical activity promotion interventions for people living with multiple sclerosis: A scoping review.
Clin Rehabil
Wilson KL, Learmonth YC, Bulley C, van der Linden ML.
PMID: 42856007 [PubMed - as supplied by publisher]
Toward regionally equitable precision medicine: microbiota‑associated mechanisms and emerging personalized strategies in multiple sclerosis.
J Transl Med
Alshinnawy AS, Rashwan EA, Swelam MS, Mohamed MR, Sayed AA.
PMID: 42855692 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 45041
Page 1 of 2253
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy